Erasca CMO's Direct Stake Goes to Zero: Investor Implications
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
Learn when to mix SP 500 and bond funds in retirement to balance risk and growth. This brief guide covers practical timing rules to help you stay on track.
28,070 articlesWhen a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
Even as global drinking declines, Anheuser-Busch InBev shows resilience through a diversified brand mix, cost discipl...
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
New real estate investors often hit a wall when income is inconsistent. DSCR loans offer a financing strategy grounde...
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...